NO965228L - Pyridylbisfosfonater for anvendelse som terapeutisk middel - Google Patents

Pyridylbisfosfonater for anvendelse som terapeutisk middel

Info

Publication number
NO965228L
NO965228L NO965228A NO965228A NO965228L NO 965228 L NO965228 L NO 965228L NO 965228 A NO965228 A NO 965228A NO 965228 A NO965228 A NO 965228A NO 965228 L NO965228 L NO 965228L
Authority
NO
Norway
Prior art keywords
bisphosphonates
pyridyl
therapeutic agents
bone diseases
pyridinylaminomethylidene
Prior art date
Application number
NO965228A
Other languages
English (en)
Other versions
NO311069B1 (no
NO965228D0 (no
Inventor
Marjaana Heikklae-Hoikka
Hannu Nikander
Ritva Hannuniemi
Leena Lauren
Terttu Kleimola
Sirpa Liukko-Sipi
Kalervo Vaeaenaenen
Raija Sellman
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO965228L publication Critical patent/NO965228L/no
Publication of NO965228D0 publication Critical patent/NO965228D0/no
Publication of NO311069B1 publication Critical patent/NO311069B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19965228A 1994-06-09 1996-12-06 Pyridylbisfosfonater for anvendelse som terapeutisk middel NO311069B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402001A SE9402001D0 (sv) 1994-06-09 1994-06-09 Pyridylbisphosphonates for use as a therapeutical agent
PCT/FI1995/000315 WO1995033466A1 (en) 1994-06-09 1995-06-02 Pyridylbisphosphonates for use as a therapeutical agent

Publications (3)

Publication Number Publication Date
NO965228L true NO965228L (no) 1996-12-06
NO965228D0 NO965228D0 (no) 1996-12-06
NO311069B1 NO311069B1 (no) 2001-10-08

Family

ID=20394303

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19965228A NO311069B1 (no) 1994-06-09 1996-12-06 Pyridylbisfosfonater for anvendelse som terapeutisk middel

Country Status (27)

Country Link
US (2) US5866556A (no)
EP (1) EP0762883B1 (no)
JP (1) JP3883137B2 (no)
KR (1) KR100363692B1 (no)
CN (1) CN1077792C (no)
AT (1) ATE208622T1 (no)
AU (1) AU691616B2 (no)
BG (1) BG63104B1 (no)
BR (1) BR9508185A (no)
CZ (1) CZ291477B6 (no)
DE (1) DE69523914T2 (no)
DK (1) DK0762883T3 (no)
EE (1) EE03475B1 (no)
ES (1) ES2162919T3 (no)
HK (1) HK1012572A1 (no)
HU (1) HU228618B1 (no)
IS (1) IS1801B (no)
NO (1) NO311069B1 (no)
NZ (1) NZ287094A (no)
PL (1) PL180705B1 (no)
PT (1) PT762883E (no)
RO (1) RO119433B1 (no)
RU (1) RU2154482C2 (no)
SE (1) SE9402001D0 (no)
SK (1) SK282650B6 (no)
UA (1) UA43918C2 (no)
WO (1) WO1995033466A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1178810B8 (en) * 1999-05-21 2005-07-27 Novartis AG Use of bisphosphonic acids for treating angiogenesis
EP1246829A1 (en) * 1999-12-17 2002-10-09 Ariad Pharmaceuticals, Inc. Novel heterocycles
US7115589B2 (en) 1999-12-17 2006-10-03 Ariad Pharmaceuticals, Inc. Purine derivatives
AU2583901A (en) 1999-12-17 2001-06-25 Ariad Pharmaceuticals, Inc. Proton pump inhibitors
PT1328277E (pt) * 2000-10-27 2007-05-31 Schering Ag Compostos bisfosfónicos para o fortalecimento do osso cortical.
US7208481B2 (en) * 2002-02-19 2007-04-24 Ilex Products, Inc. Aminodiphosphonate apolipoprotein E modulators
TW200413381A (en) * 2002-11-04 2004-08-01 Hoffmann La Roche Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
US20050010305A1 (en) * 2003-01-28 2005-01-13 Lee Francis Y. Novel bone graft composite
US20050065171A1 (en) * 2003-06-25 2005-03-24 Shakespeare William C. Substituted purine derivatives
JP2005060303A (ja) * 2003-08-12 2005-03-10 Sutaagen:Kk 不動性骨粗鬆の治療または予防剤
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447256A (en) * 1891-02-24 Apparatus for flashing and exhausting incandescent electric lamps
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DK126888A (da) * 1987-03-10 1988-09-11 Yamanouchi Pharma Co Ltd Bisphosphonsyrederivater og terapeutiske praeparater indeholdende disse forbindelser
KR880011136A (ko) * 1987-03-11 1988-10-26 모리오까 시게오 아졸- 아미노메틸렌 비스포스폰산 유도체

Also Published As

Publication number Publication date
DE69523914T2 (de) 2002-06-27
AU2569895A (en) 1996-01-04
DK0762883T3 (da) 2002-03-11
CN1077792C (zh) 2002-01-16
RU2154482C2 (ru) 2000-08-20
HU228618B1 (en) 2013-04-29
BG101116A (en) 1998-03-31
CN1149830A (zh) 1997-05-14
HK1012572A1 (en) 1999-08-06
PL317612A1 (en) 1997-04-14
ES2162919T3 (es) 2002-01-16
NZ287094A (en) 1998-04-27
EP0762883A1 (en) 1997-03-19
UA43918C2 (uk) 2002-01-15
RO119433B1 (ro) 2004-11-30
WO1995033466A1 (en) 1995-12-14
NO311069B1 (no) 2001-10-08
EE03475B1 (et) 2001-08-15
KR970703152A (ko) 1997-07-03
PT762883E (pt) 2002-05-31
SE9402001D0 (sv) 1994-06-09
BR9508185A (pt) 1997-08-12
AU691616B2 (en) 1998-05-21
CZ291477B6 (cs) 2003-03-12
EE9600191A (et) 1997-06-16
SK282650B6 (sk) 2002-10-08
PL180705B1 (pl) 2001-03-30
BG63104B1 (bg) 2001-04-30
US5866556A (en) 1999-02-02
EP0762883B1 (en) 2001-11-14
HUT75525A (en) 1997-05-28
IS4392A (is) 1996-12-02
SK157296A3 (en) 1997-06-04
HU9603375D0 (en) 1997-01-28
KR100363692B1 (ko) 2003-02-07
CZ356196A3 (en) 1997-07-16
NO965228D0 (no) 1996-12-06
US6083938A (en) 2000-07-04
ATE208622T1 (de) 2001-11-15
JP3883137B2 (ja) 2007-02-21
IS1801B (is) 2002-01-22
DE69523914D1 (en) 2001-12-20
JPH10500977A (ja) 1998-01-27

Similar Documents

Publication Publication Date Title
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
IS5198A (is) Ný efnasambönd
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE210643T1 (de) Prostaglandin-analoga zur behandlung von osteoporose
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
SE8704248D0 (sv) Medical use
DE69943107D1 (de) Behandlung von autoimmunerkrankungen
NO965228D0 (no) Pyridylbisfosfonater for anvendelse som terapeutisk middel
PT998287E (pt) Utilizacao de levobupivacaina
ATE251139T1 (de) (+)-norcisapride verwendbar bei 5-ht3 und 5-ht4 bedingten krankheiten
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
ATE252897T1 (de) Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
SE8903529D0 (sv) Medical use
BR9808233A (pt) Preparação farmacêutica
SE9303853D0 (sv) The use of an ester of inositoltrisphosphate for the preparing of medicaments
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
ATE330604T1 (de) Behandlung von manischen erkrankungen
MX9606180A (es) Piridilbisfosfonatos para utilizarse como un agente terapeutico.
CA2192456A1 (en) Pyridylbisphosphonates for use as a therapeutical agent
FR2613621B1 (fr) Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
AU7436098A (en) Use of mizolastine for preparing a medicine for treating inflammation

Legal Events

Date Code Title Description
MK1K Patent expired